Placental immunology and maternal alloimmune responses

Vox Sanguinis

Volumn 102, Issue 1, 2012, Pages 2-12

  Kumpel, B M ^a   Manoussaka, M S ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Fetomaternal haemorrhage; IgG; Immunology; Placenta; Platelets; Pregnancy

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA G ANTIGEN; IMMUNOGLOBULIN G;

ALLOIMMUNITY; AMNIOTIC FLUID CELL; ANTIBODY RESPONSE; ANTIBODY TITER; CELL KILLING; CHORION VILLUS; CYTOTOXIC T LYMPHOCYTE; DECIDUA; ERYTHROCYTE; FETOMATERNAL TRANSFUSION; FETUS (ANATOMY); GLYCOSYLATION; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; KILLER CELL; LEUKOCYTE; MACROPHAGE; MATERNAL BLOOD; MOTHER FETUS RELATIONSHIP; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; REVIEW; SYNCYTIOTROPHOBLAST; THROMBOCYTE; TROPHOBLAST;

DECIDUA; FEMALE; FETUS; GLYCOSYLATION; HUMANS; IMMUNE SYSTEM; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; ISOANTIBODIES; PLACENTA; PREGNANCY; TROPHOBLASTS;

EID: 84655169213     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01533.x     Document Type: Review

References (91)

1. Davoren A, Curtis BP, Aster RH, et al.: Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44:1220-1225.
2. Kiefel V, König C, Kroll H, et al.: Platelet articlloantibodies in transfused platelets. Transfusion 2001; 41:766-770.
3. Engelfriet CP, Reesink HW: Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors. Vox Sang 2003; 84:73-88.
4. Levine P, Katzin EM, Burnham L: Isoimmunization in pregnancy: its possible bearing on the etiology of erythroblastosis fetalis. JAMA 1941; 116:825-827.
5. Van Rood JJ, Eernisse JG, van Leeuwen A: Leococyte antibodies in sera from pregnant women. Nature 1958; 181:1735-1736.
6. Terasaki P, McClelland JD: Microdroplet assay of human serum cytotoxins. Nature 1964; 204:998-1000.
7. Rugeles MT, Shearer GM: Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol 2004; 25:348-352.
8. Ober C, Hyslop T, Elias S, et al.: Human leukocyte antigen matching and fetal loss: results of a 10year prospective study. Hum Reprod 1998; 13:33-38.
9. MacDonald KS, Embree J, Njenga S, et al.: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998; 177:551-556.
10. Tilburgs T, Scherjon SA, van der Mast BJ, et al.: Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009; 82:148-157.
11. Medawar PD: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7:320-338.
12. Ellis SA, Sargent IL, Redman CW, et al.: Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986; 59:596-601.
13. Teasdale F, Jean-Jacques G: Morphometric evaluation of the microvillous surface enlargement factor in the human placenta from mid-gestation to term. Placenta 1985; 6:375-381.
14. Simister NE, Story CM, Chen HL, et al.: An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 1996; 26:1527-1531.
15. Leach JL, Sedmak DD, Osborne JM, et al.: Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996; 157:3317-3322.
16. Ghetie V, Ward ES: FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today 1997; 18:592-598.
17. Kumpel BM, Sibley K, Jackson DJ, et al.: Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelloimmunization during pregnancy. Transfusion 2008; 48:2077-2086.
18. Chown B: Anemia from bleeding of the fetus into the mother's circulation. Lancet 1954; 1:1213-1215.
19. Sebring ES, Polesky HF: Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30:344-357.
20. Woodrow JC, Finn R: Transplacental haemorrhage. Br J Haematol 1966; 12:297-309.
21. Bowman JM, Pollock JM, Penston LE: Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986; 51:117-121.
22. Zipursky A, Israels LG: The pathogenesis and prevention of Rh immunization. Can Med Assoc J 1967; 97:1245-1257.
23. Urbaniak S: The clinical application of anti-D prophylaxis; in Hadley A, Soothill P (eds): Alloimmune Disorders of Pregnancy. Cambridge, Cambridge University Press, 2002: 97-119.
24. Turner ML, Bessos H, Fagge T, et al.: Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005; 45:1945-1956.
25. Killie MK, Husebekk A, Kjeldsen-Kragh J, et al.: A prospective study of maternal anti-HPA-1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008; 93:870-877.
26. Williamson LM, Hackett G, Rennie J, et al.: The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92:2280-2287.
27. Huppertz B, Frank HG, Kingdom JC, et al.: Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1988; 110:495-508.
28. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
29. Holdenrieder S, Stieber P, Bodenmüller H, et al.: Circulating nucleosomes in serum. Ann N Y Acad Sci 2001; 945:93-102.
30. Jones CJ, Fox H: Syncytial knots and intervillous bridges in the human placenta: an ultrastructural study. J Anat 1977; 124:275-286.
31. Nelson DM, Crouch EC, Curran EM, et al.: Trophoblast interaction with fibrin matrix. Epithelialization of perivillous deposits as a mechanism for villous repair in the human placenta. Am J Pathol 1990; 136:855-865.
32. Lo YM, Corbetta N, Chamberlain PF, et al.: Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485-487.
33. Finning KM, Martin PG, Soothill PW, et al.: Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42:1079-1085.
34. Scheffer PG, de Haas M, van der Schoot CE: Non-invasive fetal blood typing for platelet and red cell antigens. Vox Sang 2010; 99(Suppl 2):11.
35. Freixa L, Nogues N, Ibanez M, et al.: Development and validation of non-invasive approach for fetal HPA-1a genotyping using cell-free fetal DNA present in maternal plasma. Vox Sang 2010; 99(Suppl 2):22.
36. Manoussaka MS, Jackson DJ, Lock RJ, et al.: Flow cytometric characterisation of cells of differing densities isolated from human term placentae and enrichment of villous trophoblast cells. Placenta 2005; 26:308-318.
37. Jones CJ, Fox H: An ultrahistochemical study of the distribution of acid and alkaline phosphatases in placentae from normal and complicated pregnancies. J Pathol 1976; 118:143-151.
38. Hunter RJ, Pinkerton JH, Johnston H: Serum placental alkaline phosphatase in normal pregnancy and preeclampsia. Obstet Gynecol 1970; 36:536-546.
39. Smith CH, Nelson DM, King BF, et al.: Characterization of a microvillous membrane preparation from human placental syncytiotrophoblast: a morphologic, biochemical, and physiologic study. Am J Obstet Gynecol 1977; 128:190-196.
40. Kane N, Kelly R, Saunders PT, et al.: Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated by the mannose receptor. Endocrinology 2009; 150:2882-2888.
41. Moffet-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
42. Moffet A, Hiby SE: How does the maternal immune system contribute to the development of pre-eclampsia? Placenta 2007; 28(Suppl 1):S51-S56.
43. Valentin N, Gagne K, Kerdudou N, et al.: The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations. Transfusion 2007; 47:2322-2329.
44. Ponte M, Cantoni C, Biassoni R, et al.: Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, and HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96:5674-5679.
45. Tilburgs T, Schonkeren D, Eikmans M, et al.: Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol 2010; 185:4470-4477.
46. + cells by interacting with CD8. J Immunol 2000; 164:6100-6104.
47. McIntyre RH, Ganacias KG, Hunt JS: Programming of human monocytes by the uteroplacental environment. Reprod Sci 2008; 15:437-447.
48. Munn DH, Zhou M, Attwood JT, et al.: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-1193.
49. Apps R, Gardner L, Sharkey AM, et al.: A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37:1924-1937.
50. Ristich V, Liang S, Zhang W, et al.: Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005; 35:1133-1142.
51. Piccinni MP, Giudizi MG, Biagiotti R, et al.: Progesterone favours the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 clones. J Immunol 1995; 155:128-133.
52. bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008; 180:5737-5745.
53. Guerin LR, Prins JR, Robertson SA: Regulatory T cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15:517-535.
54. Schumacher A, Brachwitz N, Sohr S, et al.: Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol 2009; 182:5488-5497.
55. Heikkinen J, Möttönen M, Alanen A, et al.: Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004; 136:373-378.
56. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
57. Singh U, Nicholson G, Urban BC, et al.: Immunological properties of human decidual macrophages - a possible role in intrauterine immunity. Reproduction 2005; 129:631-637.
58. Sacks G, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today 1999; 20:114-118.
59. Sacks GP, Redman CW, Sargent IL: Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131:490-497.
60. Messerli M, May K, Hansson SR, et al.: Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 2010; 31:106-112.
61. Germain SJ, Sacks GP, Sooranna SR, et al.: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949-5956.
62. Eastlake J, Kumpel B: Developing in vitro and in vivo model systems to investigate de novo human anti-HPA-1a antibody formation in neonatal alloimmune thrombocytopenia (NAIT). Vox Sang 2010; 99(Suppl 2):19.
63. Roth I, Corry DB, Locksley RM, et al.: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539-548.
64. Hanna N, Hanna I, Hleb M, et al.: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated trophoblasts. J Immunol 2000; 164:5721-5728.
65. Manoussaka MS, Whittle CJ, Kumpel BM, et al.: Isolation and characterisation of human term trophoblasts. Immunology 1997; 92(Suppl 1):70.
66. Manoussaka MS: Characterisation and cytokine expression of human term placental trophoblasts. PhD thesis, UK, University of Bristol, 2001.
67. Piccinni MP, Scaletti C, Maggi E, et al.: Role of hormone-controlled Th1- and Th2-cytokines in successful pregnancy. J Neuroimmunol 2000; 109:30-33.
68. + regulatory cell pool during pregnancy. J Reprod Immunol 2007; 75:71-81.
69. Wegmann TG, Lin H, Guilbert L, et al.: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
70. Vanderpuye OA, Labarrere CA, McIntyre JA: A vitronectin-receptor-related molecule in human placental brush border membranes. Biochem J 1991; 280:9-17.
71. Jackson D, Kumpel B: Comparison of integrin expression on human platelets, villous trophoblasts and placental tissue using flow cytometry and immunohistochemistry. Vox Sang 2006; 91(Suppl 2):19.
72. Valentin N, Vergracht A, Bignon JD, et al.: HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990; 27:73-79.
73. Wu S, Maslanka K, Gorski J: An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997; 158:3221-3226.
74. Ahlen MT, Husebekk A, Killie MK, et al.: T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells. Blood 2009; 113:3838-3844.
75. Rayment R, Kooij TW, Zhang W, et al.: Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. J Immunol 2009; 183:677-686.
76. Jackson DJ, Murphy MF, Soothill PW, et al.: Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism. Clin Exp Immunol 2005; 142:92-102.
77. Sukati H, Bessos H, Barker RN, et al.: Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-β3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005; 45:1165-1177.
78. Bowman JM: The prevention of Rh immunization. Transfus Med Rev 1988; 2:129-150.
79. Kjeldsen-Kragh J, Killie MK, Tomter G, et al.: A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110:833-839.
80. Bolckova H, Matejkova E, Zuckove E, et al.: HLA allosensibilization of differently immunized persons. Vox Sang 2010; 99(Suppl 2):47.
81. Kumpel B, Powell T: Comparison of quantification of anti-D in antenatal sera by flow cytometry and autoanalyser. Transfus Med 2007; 17(Suppl 1):31.
82. Mattila PS, Seppala IJ, Eklund J, et al.: Quantitation of immunoglobulin classes and subclasses in anti-Rh(D) antibodies. Vox Sang 1985; 48:350-356.
83. Proulx C, Filion M, Goldman M, et al.: Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia. Br J Haematol 1994; 87:813-817.
84. Van de Winkel JGJ, Capel PJA: Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14:215-221.
85. Kumpel BM: Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sang 2007; 93:99-111.
86. Takahashi N, Ishii I, Ishihara H, et al.: Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry 1987; 26:1137-1144.
87. Pekelharing JM, Hepp E, Kamerling JP, et al.: Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women. Ann Rheum Dis 1988; 47:91-95.
88. Williams PJ, Arkwright PD, Rudd P, et al.: Short communication: selective placental transport of maternal IgG to the fetus. Placenta 1995; 16:749-756.
89. Kumpel BM, Rademacher TW, Rook GA, et al.: Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum Antibodies Hybridomas 1994; 5:143-151.
90. Shields RL, Lai J, Keck R, et al.: Lack of fucose on human IgG1N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733-26740.
91. Wuhrer M, Porcelijn L, Kapur R, et al.: Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J Proteome Res 2009; 8:450-456.